Literature DB >> 9373186

Specific reg II gene overexpression in the non-obese diabetic mouse pancreas during active diabetogenesis.

N Baeza1, D Sanchez, B Vialettes, C Figarella.   

Abstract

The reg gene, previously described in islets of 90% pancreatectomized and nicotinamide-treated rats, has been shown to be expressed in many pharmacological or surgical animal models of beta cell regeneration. We have studied the non-obese diabetic (NOD) mouse, which represents a good model of spontaneous autoimmune diabetes in which regenerative processes have recently been demonstrated. Two reg genes have been described in the mouse genome, both recognized by the human reg cDNA. In a previous work, using the human probe, we have demonstrated a strong correlation between pancreatic reg gene expression and the likelihood of developing diabetes. In the present study, we have examined the respective levels of both mouse reg I and reg II mRNA in the NOD mouse pancreas using their specific cDNA probes. We found that reg II expression was specifically prevalent compared to reg I, irrespective of sex or state of the disease. Reg II mRNA was particularly increased in overtly diabetic female mice and in cyclophosphamide-treated male mice. These data underline the need to study separately the reg genes using specific probes and show that both reg genes are subjected to various regulations, strongly suggesting that their physiological functions may be different.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9373186     DOI: 10.1016/s0014-5793(97)01241-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Activation of the Reg family genes by pancreatic-specific IGF-I gene deficiency and after streptozotocin-induced diabetes in mouse pancreas.

Authors:  Yarong Lu; André Ponton; Hiroshi Okamoto; Shin Takasawa; Pedro L Herrera; Jun-Li Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-01-31       Impact factor: 4.310

2.  Pancreatic regenerating protein I in chronic pancreatitis and aging: implications for new therapeutic approaches to diabetes.

Authors:  Martin Bluth; Cathy M Mueller; Joelle Pierre; Gordon Callender; Emad Kandil; Domenico Viterbo; Sophia L Fu; Akira Sugawara; Hiroshi Okamoto; Michael E Zenilman
Journal:  Pancreas       Date:  2008-11       Impact factor: 3.327

3.  Glutathione peroxidase-1 inhibits transcription of regenerating islet-derived protein-2 in pancreatic islets.

Authors:  Jun-Won Yun; Zeping Zhao; Xi Yan; Marko Z Vatamaniuk; Xin Gen Lei
Journal:  Free Radic Biol Med       Date:  2019-01-28       Impact factor: 7.376

4.  Pancreatic β-Cell Mass as a Pharmacologic Target in Diabetes.

Authors:  Stephen Hanley
Journal:  Mcgill J Med       Date:  2009-11-16

5.  Prospects and challenges for islet regeneration as a treatment for diabetes: a review of islet neogenesis associated protein.

Authors:  Alexander Fleming; Lawrence Rosenberg
Journal:  J Diabetes Sci Technol       Date:  2007-03

6.  Reg-II is an exocrine pancreas injury-response product that is up-regulated by keratin absence or mutation.

Authors:  Bihui Zhong; Pavel Strnad; Diana M Toivola; Guo-Zhong Tao; Xuhuai Ji; Harry B Greenberg; M Bishr Omary
Journal:  Mol Biol Cell       Date:  2007-09-26       Impact factor: 4.138

7.  Regenerating proteins and their expression, regulation and signaling.

Authors:  Abhirath Parikh; Anne-Fleur Stephan; Emmanuel S Tzanakakis
Journal:  Biomol Concepts       Date:  2011-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.